171 related articles for article (PubMed ID: 9341568)
1. Genetic testing for Alzheimer disease. Practical and ethical issues.
Roses AD
Arch Neurol; 1997 Oct; 54(10):1226-9. PubMed ID: 9341568
[TBL] [Abstract][Full Text] [Related]
2. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.
JAMA; 1995 Nov 22-29; 274(20):1627-9. PubMed ID: 7474250
[TBL] [Abstract][Full Text] [Related]
3. The genetics of Alzheimer disease and the application of molecular tests.
Tobin SL; Chun N; Powell TM; McConnell LM
Genet Test; 1999; 3(1):37-45. PubMed ID: 10464576
[TBL] [Abstract][Full Text] [Related]
4. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.
Lleó A; Blesa R; Queralt R; Ezquerra M; Molinuevo JL; Peña-Casanova J; Rojo A; Oliva R
Arch Neurol; 2002 Nov; 59(11):1759-63. PubMed ID: 12433263
[TBL] [Abstract][Full Text] [Related]
5. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease.
Roses AD
Neurogenetics; 1997 May; 1(1):3-11. PubMed ID: 10735268
[TBL] [Abstract][Full Text] [Related]
6. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.
Tsuang D; Larson EB; Bowen J; McCormick W; Teri L; Nochlin D; Leverenz JB; Peskind ER; Lim A; Raskind MA; Thompson ML; Mirra SS; Gearing M; Schellenberg GD; Kukull W
Arch Neurol; 1999 Dec; 56(12):1489-95. PubMed ID: 10593304
[TBL] [Abstract][Full Text] [Related]
7. Early-onset Alzheimer disease: when is genetic testing appropriate?
Goldman JS; Hou CE
Alzheimer Dis Assoc Disord; 2004; 18(2):65-7. PubMed ID: 15249849
[TBL] [Abstract][Full Text] [Related]
8. [Genetic factors and a polygenic model of Alzheimer's disease].
Rogaev EI
Genetika; 1999 Nov; 35(11):1558-71. PubMed ID: 10624576
[TBL] [Abstract][Full Text] [Related]
9. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
[TBL] [Abstract][Full Text] [Related]
10. Genetic testing for Alzheimer's disease.
Panegyres PK; Goldblatt J; Walpole I; Connor C; Liebeck T; Harrop K
Med J Aust; 2000 Apr; 172(7):339-43. PubMed ID: 10844923
[TBL] [Abstract][Full Text] [Related]
11. [Gene diagnosis of Alzheimer's disease and Parkinson's disease].
Tanaka S
Rinsho Byori; 2002 Oct; 50(10):965-9. PubMed ID: 12451676
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.
McConnell LM; Sanders GD; Owens DK
Genet Test; 1999; 3(1):47-53. PubMed ID: 10464577
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
14. [Genetic counseling and testing for families with Alzheimer's disease].
Kowalska A
Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
[TBL] [Abstract][Full Text] [Related]
15. Candidate gene association studies in sporadic Alzheimer's disease.
Combarros O; Alvarez-Arcaya A; Sánchez-Guerra M; Infante J; Berciano J
Dement Geriatr Cogn Disord; 2002; 14(1):41-54. PubMed ID: 12053131
[TBL] [Abstract][Full Text] [Related]
16. Exploring the etiology of Alzheimer disease using molecular genetics.
Lendon CL; Ashall F; Goate AM
JAMA; 1997 Mar; 277(10):825-31. PubMed ID: 9052714
[TBL] [Abstract][Full Text] [Related]
17. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.
Laws SM; Hone E; Gandy S; Martins RN
J Neurochem; 2003 Mar; 84(6):1215-36. PubMed ID: 12614323
[TBL] [Abstract][Full Text] [Related]
18. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.
Post SG; Whitehouse PJ; Binstock RH; Bird TD; Eckert SK; Farrer LA; Fleck LM; Gaines AD; Juengst ET; Karlinsky H; Miles S; Murray TH; Quaid KA; Relkin NR; Roses AD; St George-Hyslop PH; Sachs GA; Steinbock B; Truschke EF; Zinn AB
JAMA; 1997 Mar; 277(10):832-6. PubMed ID: 9052715
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.
Roses AD
Ann N Y Acad Sci; 1996 Dec; 802():50-7. PubMed ID: 8993484
[TBL] [Abstract][Full Text] [Related]
20. To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.
Rahman B; Meiser B; Sachdev P; Barlow-Stewart K; Otlowski M; Zilliacus E; Schofield P
Genet Test Mol Biomarkers; 2012 Aug; 16(8):935-42. PubMed ID: 22731638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
